Aurinia Pharmaceuticals

NasdaqGM:AUPH Stock Report

Mkt Cap: US$665.1m

Aurinia Pharmaceuticals Future Growth

How is Aurinia Pharmaceuticals forecast to perform in the next 1 to 3 years based on estimates from 8 analysts?

Future Growth Score

2/6

Future Growth Score 2/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


53.5%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts

NasdaqGM:AUPH - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2024199-69-96-837
12/31/2023137-128-121-1008
12/31/2022133-121-135-1048
9/30/2022129-115-116-116N/A
6/30/202288-157-147-141N/A
3/31/202266-168-157-151N/A
12/31/202146-181-165-158N/A
9/30/202172-156-138-129N/A
6/30/202158-148-125-117N/A
3/31/202151-127-109-101N/A
12/31/202050-103-77-70N/A
9/30/20200-129-104-98N/A
6/30/20200-110-83-82N/A
3/31/20200-102-73-73N/A
12/31/20190-88-64-64N/A
9/30/20190-57-52-52N/A
6/30/20190-52-51-51N/A
3/31/20190-61-50-50N/A
12/31/20180-53-52-52N/A
9/30/20180-53-47-47N/A
6/30/20180-48-44-44N/A
3/31/20180-34-46-46N/A
12/31/20170-71-41-41N/A
9/30/20170-76-37-36N/A
6/30/20170-70-32-32N/A
3/31/20170-71-23-23N/A
12/31/20160-23-19-19N/A
9/30/20160-19-19-19N/A
6/30/20160-17N/A-20N/A
3/31/20160-14N/A-19N/A
12/31/20150-19N/A-18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: AUPH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: AUPH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: AUPH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: AUPH's revenue (26.3% per year) is forecast to grow faster than the US market (7% per year).

High Growth Revenue: AUPH's revenue (26.3% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if AUPH's Return on Equity is forecast to be high in 3 years time


Discover growth companies